We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Regulation of antibody immunotherapy by fine-tuning FcR interactions

Video   Apr 22, 2013

 

About the Speaker


Mark Cragg is a Professor in Experimental Cancer Biology at the Cancer Sciences Division of Southampton University School of Medicine, UK. He obtained his PhD in 1998 and did his postdoctoral studies with Martin Glennie in Southampton and then Andreas Strasser at the Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia. He has published over 60 papers, many in high impact journals such as the Journal of Clinical Investigation, PNAS, Plos Medicine and Blood and leads a dynamic research group interested in all aspects of how therapeutics such as antibodies result in tumour regression and how they can be improved.
Abstract

Monoclonal antibodies (mAb) represent a growing class of ‘block-buster’ cancer drugs and so understanding of their modes of action is critical. Here, we present evidence that different mAb interact with Fc receptors differently in order to achieve their therapeutic activities.

 
 
 
Advertisement
 

Recommended Videos

Cancer Research During COVID-19

Video

Cancer Research UK (CRUK) scientists share how they have responded to the COVID-19 pandemic, and how CRUK is continuing to support people affected by cancer through life-saving research.

WATCH NOW

How Tear Gas Affects Your Body

Video

2-Chlorobenzalmalononitrile, better known as CS gas, is one of the most common tear gases used in the United States today, but did you know it’s not actually a gas? ACS Reactions break down how it works, a bit of its history and the best ways to recover if you’re hit with it.

WATCH NOW

Teach Me in 10 - CRISPR, Cell Therapies and Drug Discovery With Dr Theo Roth

Video

This instalment of Teach Me in 10 features Dr Theo Roth, whose work bridges a number of different fields, such as genome engineering, cancer immunology and cell-based therapies.

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Cancer Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE